Article Information
History
- February 3, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Hanan Shaharuddin1,2,†,
- Victoria Wang1,2,†,
- Roberta S. Santos1,2,†,
- Andrew Gross1,2,
- Yizhou Wang3,4,
- Harneet Jawanda5,
- Yi Zhang5,
- Wohaib Hasan3,5,6,
- Gustavo Garcia Jr.7,
- Vaithilingaraja Arumugaswami*,7,8 and
- Dhruv Sareen*,1,2,3,9
- 1Board of Governors Regenerative Medicine Institute. Cedars-Sinai Medical Center, Los Angeles, CA, USA
- 2Cedars-Sinai Biomanufacturing Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA
- 3Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA
- 4Genomics Core, Cedars-Sinai Medical Center, Los Angeles, CA, USA
- 5Biobank and Translational research Core, Samuel Oschin Comprehensive Cancer Institute (SOCCI), Cedars-Sinai Medical Center, Los Angeles, CA, USA
- 6Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA
- 7Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA
- 8Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California, Los Angeles, Los Angeles, CA 90095, USA
- 9iPSC Core, David and Janet Polak Foundation Stem Cell Core Laboratory. Cedars-Sinai Medical Center, Los Angeles, CA, USA
- ↵*Corresponding authors: Dhruv Sareen. Cedars-Sinai Biomanufacturing Center. 8687 Melrose Blvd., Ste. B227, Rm. A252. West Hollywood, CA 90069, USA. Email: dhruv.sareen{at}cshs.org. Vaithilingaraja Arumugaswami. Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA. Email: varumugaswami{at}mednet.ucla.edu
↵† These authors contributed equally.
Posted February 03, 2021.
